Suscribirse

Evidence-based organ allocation - 08/09/11

Doi : 10.1016/S0002-9343(99)00166-7 
Stefanos A Zenios, PhD a, Lawrence M Wein, PhD b, Glenn M Chertow, MD, MPH c,
a Graduate School of Business (SAZ), Stanford University, Stanford, California, USA 
b Sloan School of Management (LMW), Massachusetts Institute of Technology, Cambridge, Massachusetts, USA 
c Renal Division (GMC), Department of Medicine, Brigham and Women’s Hospital, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA 

*Requests for reprints should be addressed to Glenn M. Chertow, MD, MPH, Division of Nephrology, University of California, San Francisco, 672 Health Sciences East, San Francisco, California 94143-0532

Abstract

BACKGROUND: There are not enough cadaveric kidneys to meet the demands of transplant candidates. The equity and efficiency of alternative organ allocation strategies have not been rigorously compared.

METHODS: We developed a five-compartment Monte Carlo simulation model to compare alternative organ allocation strategies, accommodating dynamic changes in recipient and donor characteristics, patient and graft survival rates, and quality of life. The model simulated the operations of a single organ procurement organization and attempted to predict the evolution of the transplant waiting list for 10 years. Four allocation strategies were compared: a first-come first-transplanted system; a point system currently utilized by the United Network of Organ Sharing; an efficiency-based algorithm that incorporated correlates of patient and graft survival; and a distributive efficiency algorithm, which had an additional goal of promoting equitable allocation among African-American and other candidates.

RESULTS: A 10-year computer simulation was performed. The distributive efficiency policy was associated with a 3.5% ± 0.8% (mean ± SD) increase in quality-adjusted life expectancy (33.9 months vs 32.7 months), a decrease in the median waiting time to transplantation among those who were transplanted (6.6 months vs 16.3 months), and an increase in the overall likelihood of transplantation (61% vs 45%), compared with the United Network of Organ Sharing algorithm. Improved equity and efficiency were also seen by race (African-American vs other), sex, and age (<50 or ≥50 years). Sensitivity analyses did not appreciably change the qualitative results.

CONCLUSION: Evidence-based organ allocation strategies in cadaveric kidney transplantation would yield improved equity and efficiency measures compared with existing algorithms.

El texto completo de este artículo está disponible en PDF.

Esquema


 Supported in part by HCFA Grant 30-P-90673/1-01 and National Science Foundation Grant DDM-9057297. The data in the 1994 Public Use Data Set were supplied by the United Network of Organ Sharing, but the authors are responsible for their analysis and interpretation.


© 1999  Excerpta Medica Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 107 - N° 1

P. 52-61 - juillet 1999 Regresar al número
Artículo precedente Artículo precedente
  • Determinants of retinopathy progression in type 1 diabetes mellitus
  • Robert A Cohen, Charles H Hennekens, William G Christen, Andrzej Krolewski, David M Nathan, Michael J Peterson, Frances LaMotte, JoAnn E Manson
| Artículo siguiente Artículo siguiente
  • Antibiotics in acute bronchitis: a meta-analysis
  • Stephen Bent, Sanjay Saint, Eric Vittinghoff, Deborah Grady

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.